EVs inhibited fibroblast activation by downregulating the expression of TGF-β1 in the dermis, significantly reduced the infiltration of inflammatory cells and inhibited the release of inflammatory factors in the skin of BLM-induced SSc mice. Here, TGFB1 is linked to systemic sclerosis.